
Uncovering the Future: A Comprehensive Recap of Aytu BioPharma Inc.’s Q4 2024 Earnings Call
Aytu BioPharma, Inc. Q4 2024 Earnings Call Highlights Introduction Welcome to the Aytu BioPharma’s Fiscal 2024 Q4 Earnings Call. Robert Blum from Lytham Partners, Josh Disbrow – Chief Executive Officer, and Mark Oki – Chief Financial Officer will be presenting on the call. The call will be moderated by Naz Rahman from Maxim Group. The…